Randomized Phase II trial with cetuximab and cisplatin in the treatment of ER-negative, PgRnegative, HER2-negative metastatic breast carcinoma (“basal-like”)
BALI-1
Clinical Trial Program
Randomized Phase II trial with cetuximab and cisplatin in the treatment of ER-negative, PgRnegative, HER2-negative metastatic breast carcinoma (“basal-like”)
Phase II
Status
Finished
Tumour subtype:
TNBC
Scenario
Localmente avanzado o metastático
SPONSOR
COLLABORATORS
PRINCIPAL INVESTIGATORS
José Baselga, MD, PhD (Hospital Universitari Vall d'Hebron, Barcelona)
Sites
